- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
GS 1
Social issues Seeds of a million tyrannies: (Indian Express, Editorial)
The anti-minority violence India is witnessing is significant not principally because of its scale but because of the processes engendering it.
Law, morality, triple talaq: (Indian Express, Editorial)
The issue is not whether triple talaq is an essential practice of Islam, but whether it is an essential practice of the Hanafi school.
GS 2
Government policies
Weapons not for showing off, says High Court: (The Hindu)
GS 3
Indian Economy. Planning, Growth and Employment
G20 hails India’s labour reforms, start-up policy: (The Hindu)
Acknowledging the steps being taken by India for sustainable and inclusive growth as well as support to global economy, the G20 has praised the initiatives in the country for promoting ease of doing business, start-up funding and labour reforms.
Demystifying debt funds as an investment option: (The Hindu)
Science and Tech
Easier access to H1N1 medicines raises fears of drug resistance: (The Hindu)
Concerns regarding a build-up of resistance to antiviral drugs used to treat swine flu are surfacing, after two such drugs — Oseltamivir and Zanamivir — were taken off the restrictive Schedule X of the Drugs and Comestics Rules. Now under Schedule H1, the drugs can be stocked by all chemists.
Prelims Related News
Curcumin nanoparticles found to shorten TB treatment time:
Curcumin, the basic ingredient of turmeric, when administered in a nanoparticle formulation has several favourable properties in the treatment of tuberculosis in mice, researchers have found.



